热门资讯> 正文
ABVC BioPharma获得50，000美元增量许可费，股价攀升
2024-10-22 21:09
- ABVC BioPharma (NASDAQ:ABVC) has secured an additional $50,000 in licensing fees from AiBtl BioPharma, it said on Tuesday, sending shares up in premarket trade.
- ABVC (ABVC) shares rose +4.89% premarket to $0.57.
- With this payment, ABVC has received a total of $346,000 in licensing fees from its strategic partners.
- ABVC has received 23M AiBtl shares as part of the first milestone of the licensing fees and will obtain royalties up to $100M after the product launches.
- Source: Press Release
More on ABVC BioPharma
- Financial information for ABVC BioPharma
推荐文章
黄仁勋年内三度访华！H20重返中国市场，释放了什么信号？
美股机会日报 | 6月零售数据高于市场预期；台积电绩后涨超3%
美股“七巨头”迎特朗普关税后首次大考！Q2能否交出亮眼成绩单，继续引领美股上涨？
华盛早报丨TACO交易再现！特朗普闪电改口“解雇鲍威尔”；美国众议院加密货币立法进程受阻
财报前瞻 | 特斯拉Q2营收料下滑10%！股价销量双杀下，马斯克能否逆转局势？
美股机会日报 | 低于市场预期！美国6月PPI同比增长2.3%；特斯拉官宣Model Y L
华盛早报丨事关中美关税！美财长最新放风；“加密周”突发！多项加密货币法案遭众议院否决
美股机会日报 | 6月CPI符合预期！英伟达盘前涨超4%，今夜有望再创新高
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
